- Home
- ITRG vs IKT Comparison
ITRG vs IKT Comparison
Compare ITRG & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRG
- IKT
- Stock Information
- Founded
- ITRG 1997
- IKT 2008
- Country
- ITRG Canada
- IKT United States
- Employees
- ITRG N/A
- IKT N/A
- Industry
- ITRG Precious Metals
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- ITRG Basic Materials
- IKT Health Care
- Exchange
- ITRG Nasdaq
- IKT Nasdaq
- Market Cap
- ITRG 156.9M
- IKT 159.2M
- IPO Year
- ITRG N/A
- IKT 2020
- Fundamental
- Price
- ITRG $1.15
- IKT $2.97
- Analyst Decision
- ITRG Strong Buy
- IKT Buy
- Analyst Count
- ITRG 1
- IKT 2
- Target Price
- ITRG $2.00
- IKT $8.00
- AVG Volume (30 Days)
- ITRG 458.4K
- IKT 242.4K
- Earning Date
- ITRG 03-26-2025
- IKT 03-26-2025
- Dividend Yield
- ITRG N/A
- IKT N/A
- EPS Growth
- ITRG N/A
- IKT N/A
- EPS
- ITRG N/A
- IKT N/A
- Revenue
- ITRG N/A
- IKT $1.00
- Revenue This Year
- ITRG N/A
- IKT N/A
- Revenue Next Year
- ITRG $69.44
- IKT N/A
- P/E Ratio
- ITRG N/A
- IKT N/A
- Revenue Growth
- ITRG N/A
- IKT N/A
- 52 Week Low
- ITRG $0.64
- IKT $1.12
- 52 Week High
- ITRG $1.28
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- ITRG 55.92
- IKT 57.38
- Support Level
- ITRG $1.14
- IKT $2.20
- Resistance Level
- ITRG $1.20
- IKT $2.37
- Average True Range (ATR)
- ITRG 0.07
- IKT 0.26
- MACD
- ITRG -0.00
- IKT 0.11
- Stochastic Oscillator
- ITRG 50.00
- IKT 72.87
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of highly prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.